Location History:
- Chesterfield, MO (US) (2011)
- St. Louis, MO (US) (2015 - 2019)
Company Filing History:
Years Active: 2011-2019
Title: Kevin Kayser: Innovator in Viral Resistance and Protein Production
Introduction
Kevin Kayser is a prominent inventor based in St. Louis, MO (US), known for his significant contributions to biotechnology. With a total of six patents to his name, he has made remarkable advancements in the fields of viral resistance and recombinant protein production.
Latest Patents
Among his latest patents, one notable invention is titled "Viral resistant cells and uses thereof." This invention provides mammalian cell lines that have been genetically engineered to resist viral entry and propagation. It also outlines methods for using these cell lines to reduce or prevent viral contamination in biologic production systems. Another significant patent is "Production of recombinant proteins with simple glycoforms." This invention offers cell lines deficient in mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I (Mgat1). It includes methods for producing these Mgat1 deficient cell lines and utilizing them for the production of recombinant proteins with simple glycoforms.
Career Highlights
Kevin Kayser has built a successful career at Sigma-Aldrich Co. LLC, where he has been instrumental in driving innovation in biotechnology. His work has not only advanced scientific understanding but has also contributed to practical applications in the industry.
Collaborations
Throughout his career, Kevin has collaborated with talented individuals such
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.